Old Web
English
Sign In
Acemap
>
authorDetail
>
Jeanie Tang
Jeanie Tang
EZH2
Medicine
Histone methyltransferase
Tazemetostat
Pathology
3
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase Ib/II open-label study of tazemetostat (TAZ) plus enzalutamide (E) or abiraterone/prednisone (A/P) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC).
2020
Journal of Clinical Oncology
Wassim Abida
Thomas Bradley
Arash Rezazadeh
Lawrence Ivan Karsh
Ashley E. Ross
Daniel R. Saltzstein
Evren Kocabas Argon
Anthony Hamlett
Jeanie Tang
Deyaa Adib
Show All
Source
Cite
Save
Citations (0)
A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma.
2016
Journal of Clinical Oncology
Mark Agulnik
Nizar M. Tannir
Joseph Gerald Pressey
Mrinal M. Gounder
Gregory M. Cote
Maria Roche
Susan Doleman
Stephen J. Blakemore
Alicia Clawson
Scott R. Daigle
Jeanie Tang
Peter Ho
George D. Demetri
Show All
Source
Cite
Save
Citations (17)
A phase I study of the EZH2 inhibitor tazemetostat in pediatric subjects with relapsed or refractory INI1-negative tumors or synovial sarcoma.
2016
Journal of Clinical Oncology
Susan N. Chi
Geoffrey McCowage
Lindsey M. Hoffman
Margaret E. Macy
Susan Doleman
Stephen J. Blakemore
Alicia Clawson
Scott R. Daigle
Jeanie Tang
Maria Roche
Peter Ho
Show All
Source
Cite
Save
Citations (7)
1